![](https://investorshub.advfn.com/uicon/275298.png?cb=1541149751)
Wednesday, April 01, 2020 6:58:44 PM
I guarantee you they are well aware of all opportunities.
Additionally -- attention to the pulmonary markets is way up as a result of cv-19 -- creating a fundamentally extremely bullish environment for their exact market space at least the next 5+ years. Think about it -- they are converting already in use worldwide leading oral/capsule pills into inhalers, increasing safety, lowering dosage, and being more effective.
Pulmazole is their first G2M attempt, with Cipla, a 65% respiratory market share in India. They are projecting $3.5-$5B worldwide -- they are not fucking around. The base-product (Itraconazole) is now being researched in clincal Trials in Belgium as of 3/25 for CV-19. FDA has already fast-tracked Pulmazole just 60 days ago.
J&J joined up under their lung cancer initiative. They put $100M cash on the table -- that's 4x their first deal of $22M with cipla.
It's pretty clear what is going on. Exact prices when, a fools errand and missing the point. The stakes are heating up every day. All imo.
PT1: $5
PT2: $10
PT3: $20
PTMania: $50-$100+
All comments are solely my opinion. Please formulate your own opinion and act on your own accord on all actions you take.
Recent PULM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 01:20:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 01:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 08:05:37 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/31/2024 04:15:13 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 12:45:16 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/17/2024 08:06:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 01:00:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 01:20:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 01:05:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:06:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 02:00:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 02:20:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 02:05:40 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM